Literature DB >> 30275534

Shining light on the significance of NK cell CD56 brightness.

Sophie M Poznanski1, Ali A Ashkar2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30275534      PMCID： PMC6269508          DOI： 10.1038/s41423-018-0163-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  12 in total

1.  The breast tumor microenvironment alters the phenotype and function of natural killer cells.

Authors:  Tamara Krneta; Amy Gillgrass; Marianne Chew; Ali A Ashkar
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

2.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

Authors:  Bibiana Bielekova; Marta Catalfamo; Susan Reichert-Scrivner; Amy Packer; Magdalena Cerna; Thomas A Waldmann; Henry McFarland; Pierre A Henkart; Roland Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

3.  Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

Authors:  Jacob Hanna; Debra Goldman-Wohl; Yaron Hamani; Inbal Avraham; Caryn Greenfield; Shira Natanson-Yaron; Diana Prus; Leonor Cohen-Daniel; Tal I Arnon; Irit Manaster; Roi Gazit; Vladimir Yutkin; Daniel Benharroch; Angel Porgador; Eli Keshet; Simcha Yagel; Ofer Mandelboim
Journal:  Nat Med       Date:  2006-08-06       Impact factor: 53.440

4.  Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.

Authors:  Tina Nham; Sophie M Poznanski; Isabella Y Fan; Mira M Shenouda; Marianne V Chew; Amanda J Lee; Fatemeh Vahedi; Yalda Karimi; Martin Butcher; Dean A Lee; Hal Hirte; Ali A Ashkar
Journal:  Cancer Immunol Immunother       Date:  2018-01-03       Impact factor: 6.968

5.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 6.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

7.  Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model.

Authors:  Sophie M Poznanski; Tina Nham; Marianne V Chew; Amanda J Lee; Joanne A Hammill; Isabella Y Fan; Martin Butcher; Jonathan L Bramson; Dean A Lee; Hal W Hirte; Ali A Ashkar
Journal:  Cancer Immunol Res       Date:  2018-07-17       Impact factor: 11.151

8.  CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

Authors:  Julia A Wagner; Maximillian Rosario; Rizwan Romee; Melissa M Berrien-Elliott; Stephanie E Schneider; Jeffrey W Leong; Ryan P Sullivan; Brea A Jewell; Michelle Becker-Hapak; Timothy Schappe; Sara Abdel-Latif; Aaron R Ireland; Devika Jaishankar; Justin A King; Ravi Vij; Dennis Clement; Jodie Goodridge; Karl-Johan Malmberg; Hing C Wong; Todd A Fehniger
Journal:  J Clin Invest       Date:  2017-10-03       Impact factor: 14.808

9.  Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.

Authors:  Upkar S Gill; Dimitra Peppa; Lorenzo Micco; Harsimran D Singh; Ivana Carey; Graham R Foster; Mala K Maini; Patrick T F Kennedy
Journal:  PLoS Pathog       Date:  2016-08-03       Impact factor: 6.823

10.  CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.

Authors:  Antoni Chan; Deng-Li Hong; Ann Atzberger; Simon Kollnberger; Andrew D Filer; Christopher D Buckley; Andrew McMichael; Tariq Enver; Paul Bowness
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422
View more
  9 in total

1.  Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.

Authors:  Hyun Gul Yang; Moon Cheol Kang; Tae Yoon Kim; Injung Hwang; Hyun Tak Jin; Young Chul Sung; Ki-Seong Eom; Sae Won Kim
Journal:  J Immunother Cancer       Date:  2019-05-24       Impact factor: 13.751

2.  Technical advances in NK cell-based cellular immunotherapy.

Authors:  Fang Fang; Wei Wang; Minhua Chen; Zhigang Tian; Weihua Xiao
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

Review 3.  Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors.

Authors:  Sooyeon Oh; Joo-Ho Lee; KyuBum Kwack; Sang-Woon Choi
Journal:  Cancers (Basel)       Date:  2019-10-11       Impact factor: 6.639

Review 4.  The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy.

Authors:  Haoyu Sun; Cheng Sun
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

5.  Forest Bathing Always Makes Sense: Blood Pressure-Lowering and Immune System-Balancing Effects in Late Spring and Winter in Central Europe.

Authors:  Agnes Peterfalvi; Matyas Meggyes; Lilla Makszin; Nelli Farkas; Eva Miko; Attila Miseta; Laszlo Szereday
Journal:  Int J Environ Res Public Health       Date:  2021-02-20       Impact factor: 3.390

6.  Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing.

Authors:  Juan M Falcon-Perez; Rosa Maria Hernandez; Kevin Las Heras; Félix Royo; Clara Garcia-Vallicrosa; Manoli Igartua; Edorta Santos-Vizcaino
Journal:  Stem Cell Res Ther       Date:  2022-04-08       Impact factor: 6.832

7.  Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Charline Sommer; Sebastian Böhlen; Christina Ziemann; Susann Dehmel; Armin Braun; Uta Sandy Tretbar; Stephan Klöß; Axel Schambach; Michael Morgan; Dennis Löffler; Christoph Kämpf; Conny Blumert; Kristin Reiche; Jana Beckmann; Ulla König; Bastian Standfest; Martin Thoma; Gustavo R Makert; Sebastian Ulbert; Uta Kossatz-Böhlert; Ulrike Köhl; Anna Dünkel; Stephan Fricke
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

8.  29-Color Flow Cytometry: Unraveling Human Liver NK Cell Repertoire Diversity.

Authors:  Iva Filipovic; Isabella Sönnerborg; Benedikt Strunz; Danielle Friberg; Martin Cornillet; Laura Hertwig; Martin A Ivarsson; Niklas K Björkström
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

9.  Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.

Authors:  Alessandra Zecca; Valeria Barili; Danila Rizzo; Andrea Olivani; Elisabetta Biasini; Diletta Laccabue; Raffaele Dalla Valle; Carlo Ferrari; Elisabetta Cariani; Gabriele Missale
Journal:  Cells       Date:  2021-03-10       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.